Global Pulmonary Arterial Hypertension (PAH) Market (By Drug Class, By Region, By Country): Opportunities and Forecasts (2016-2021) - (By Drug Class -Endothelin Receptor Antagonists, Prostacyclin & Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others; By Region-North America, Europe, APAC, Latin America, MEA; By Country- USA, Canada, UK, Germany, Japan, Brazil, South Africa)
Description-
A
comprehensive research report created through extensive primary
research (inputs from industry experts, companies, stakeholders) and
secondary research, the report aims to present the analysis of the
global Pulmonary Arterial Hypertension (PAH) market on the
basis of Drug Class (Endothelin Receptor Antagonists, Prostacyclin,
Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others),
By Region (North
America, Europe, APAC, Latin America, MEA) and By Country (USA,
Canada, UK, Germany, Japan, Brazil, South Africa).
The
report suggests that rising development of pipeline drugs in PAH
combined with the growing awareness of the disease majorly in
developed countries has resulted in the growth of PAH market. Also,
the market for Pulmonary Arterial Hypertension (PAH) is growing
moderately due to newer launches of pipeline drugs that target
different pathways to supress the symptoms of the disease. Early
diagnosis of the disease has played a pivotal role in number of
patients undergoing treatment.
Among
the drug classes, the market is expected to be driven by ERAs.
However, growing number of drugs under prostacyclin are expected to
witness tremendous growth in the forecast period.
Scope
of the Report
The
report provides Segmentation by Drug Class
- Endothelin receptor antagonists
- Prostacyclin and Prostacyclin Analogs
- Phosphodiesterase V Inhibitors
- Others
The
report provides coverage by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)
The
report provides coverage by Country
- USA
- Canada
- UK
- Germany
- Japan
- Brazil
- South Africa
Customization
of the Report
The
report could be customized according to the client’s specific
research requirements. No additional cost will be required to pay for
limited additional research.
Table
of Content
1.
Research Methodology
2.
Executive Summary
3.
Strategic Recommendations
3.1.
PAH Market to Grow at a Moderate Rate
3.2.
ERA to the Drive the PAH Market
3.3.
PAH Market to be Dominated by North America and Europe
4.
Global PAH Market: An Overview
4.1.
Product Overview
4.1.1.
Global PAH Market, By Value 2011-2015
4.1.2.
Global PAH Market, By Value 2016-2021F
4.1.3
Global PAH Market: By Drug Class Type, By Value (2016E-2021F)
For
More Information Kindly Contact:
ResearchMoz
Global Pvt. Ltd.
90
State Street,
Albany,
NY 12207,
United
States
866-997-4948
(Us-Canada Toll Free),
+1-518-621-2074,
Email
to:
sales@researchmoz.us,
Comments
Post a Comment